法国巴黎消息:Eflornithine治疗获得性免疫缺损综合征(AIDS)病人的卡氏肺囊虫肺炎(PCP)有效。3名研究者在巴黎召开的国际AIDS会议上各自报告了研究情况。这种药物对危重病例及常规治疗无效的AIDS病人尤为适宜。60％左右的AIDS病人并发PCP。美国辛辛那提Merrell Dow研究所的J LBarlow医师报告了一组研究情况,在完成 Paris, France: Eflornithine is effective in treating Pneumocystis carinii pneumonia (PCP) in patients with Acquired Immune Deficiency Syndrome (AIDS). Three researchers reported on the status of their research at the International AIDS Conference in Paris. This medicine is particularly suitable for critically ill patients and AIDS patients who are ineffective in conventional treatment. About 60% of AIDS patients with PCP. J LBarlow, MD, from the Merrell Dow Institute in Cincinnati, USA, reported on a set of studies that, when completed